Partner Article
Northwich Veterinary pharmaceutical company report gross profit up 5%
Northwich based veterinary pharmaceutical business Dechra Pharmaceuticals PLC report gross profit is up 5% at £56.9 million.
The cheshire based company released its half yearly report today, reporting strong revenue growth however profits have been influenced by strong currency headwinds.
The company report that currency problems will continue to affect its financial performance throughout the year.
The group have continued its expansion plans opening in Italy in March 2014 and begining trading in Canada in January 2015.
Chief Executive Officer, Ian Page, said: “The Group has made a solid start to the year with continued momentum in Europe and a strong performance in the US.
“Our focus on executing our strategy is delivering value to shareholders.
“Our core portfolio demonstrates growth, our product pipeline is delivering results and our global expansion is progressing well.”
This was posted in Bdaily's Members' News section by Sophia Taha .
How businesses can reduce workplace safety risks with custom solutions
Tech firm unveils jobs plan after £530,000 backing
SMEs urged to think big at Newcastle event
B Corp is a commitment, not a one-time win
Government must get in gear on vehicle transition
A legacy in stone and spirit
Shaping the future: Your guide to planning reforms
The future direction of expert witness services
Getting people into gear for a workplace return
What to expect in the Spring Statement
Sunderland leading way in UK office supply market
Key construction developments in 2025